萬邦德(002082.SZ):銀杏葉滴丸中選中成藥省際聯盟集中帶量採購
格隆匯12月28日丨萬邦德(002082.SZ)公佈,2021年12月21日,公司全資子公司萬邦德製藥集團有限公司(以下簡稱“萬邦德製藥”)參加了中成藥省際聯盟集採領導小組辦公室組織的中成藥省際聯盟集中帶量採購的投標工作。根據中成藥省際聯盟集採領導小組辦公室於2021年12月27日發佈的《中成藥省際聯盟集中帶量採購公吿(第4號)》,萬邦德製藥國家中藥保護品種銀杏葉滴丸中選本次集中採購。
銀杏葉滴丸適應症:心腦血管系統藥,主要治療淤血阻絡引起的胸痺、心痛、中風、半身不遂、舌強語蹇;冠心病穩定型心絞痛、腦梗塞等。
中選產品銀杏葉滴丸為公司的核心產品,2020年度在本次省際聯盟覆蓋區域銷售量為5.46億丸,佔銀杏葉滴丸銷量的31.60%。
此次公司銀杏葉滴丸中選,鞏固了十九個省際聯盟區域的市場份額,產品銷售價格有一定程度下降,但有利於減輕患者用藥負擔,提高銀杏葉滴丸的可及性、市場佔有率和品牌影響力,對公司未來市場銷售產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.